Mira Pharmaceuticals Inc.

Mira Pharmaceuticals Inc. operates in the biotechnology industry, focusing on the research and development of novel therapeutics. The company is dedicated to advancing pharmaceuticals that address unmet medical needs, primarily targeting neurological and neuropsychiatric disorders. Through innovative drug development processes, Mira Pharmaceuticals aims to improve quality of life for patients suffering from conditions such as anxiety, depression, and cognitive impairments. This approach involves sophisticated technologies for drug formulation and delivery, ensuring efficient and effective treatment options. The company’s role in the financial market centers around its potential to introduce groundbreaking drugs, drawing attention from investors, healthcare professionals, and regulatory bodies. By addressing significant healthcare challenges, Mira Pharmaceuticals not only contributes to scientific progress but also plays a crucial part in the healthcare industry, impacting portfolios that focus on cutting-edge medical innovations and pharmaceutical advancements.

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Mr. Erez Aminov

Headquarters

Miami, FL, United States

Website

mirapharmaceuticals.com